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Despite the acknowledged impact of the tumor stroma on breast cancer devel-
opment and progression, the molecular basis of such effects remain partially unex-
plained. We previously reported that breast cancer-associated fibroblasts (CAFs) 
induced epithelial-mesenchymal transition and an increase in cell membrane fluidity 
and migration speed in poorly (MCF-7) and highly invasive (MDA-MB-231) breast 
cancer cells. More recently, in order to better define the mechanisms responsible for 
the CAF-promoted tumor cell migration, we investigated the role of Stearoyl-CoA 
desaturase 1 (SCD1), the main enzyme regulating membrane fluidity, and demon-
strated its CAF-triggered up-regulation as well as its crucial role in the migratory 
ability of the above tumor cells. Besides SCD1 induction, a CAF-promoted enhance-
ment in the protein level and/or activity of the SCD1 transcription factor, the sterol 
regulatory element-binding protein 1 (SREBP1), was observed. Moreover, the influ-
ence of stroma-derived signals in cancer cell migration speed was proved by cell 
tracking analysis in the presence of neutralizing antibodies to hepatocyte growth fac-
tor, transforming growth factor-β or basic fibroblast growth factor, where a marked 
reduction or abolishment of the fibroblast-triggered increase in cancer cell migration 
speed was observed. 
In the last part of this study, in order to verify if soluble CAF-derived factors 
stimulate breast cancer cell migration in a SCD1-dependent manner, tumor cells were 
exposed to CAF-conditioned medium (CM) and their migration evaluated by scratch 
assay in the presence of a small molecule inhibitor of SCD1. Moreover, to assess if the 
induction of SCD1 expression by CAFs might occur via SREBP1, the desaturase levels 
were also determined in SREBP1-inhibited tumor cells.
These latest investigations indicate that SCD1 contributes to the promotion of 
breast cancer cell migration by CAF-derived soluble factors, since the desaturase inhi-
bition completely suppressed the stimulatory effect of CAF-CM on tumor cell migra-
tion. SREBP1 inhibition impaired CAF-mediated up-regulation of SCD1 in poorly 
invasive but not in highly invasive tumor cells, in which SREBP1-independent mech-
anisms may account for the enhancement of SCD1 levels.
These results provide further insights in understanding the role of CAFs in pro-
moting tumor cell migration, which may help to design new stroma-based therapeu-
tic strategies.
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